{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:12:58Z","timestamp":1793261578703,"version":"4.5.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.pain.2008.10.005","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T07:32:44Z","timestamp":1226475164000},"page":"60-69","source":"Crossref","is-referenced-by-count":153,"title":["Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin"],"prefix":"10.1097","volume":"141","author":[{"given":"Parisa","family":"Gazerani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Spicina","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Staahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asbj\u00f8rn Mohr","family":"Drewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Arendt-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210112","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","article-title":"Evidence for antinociceptive activity of botulinum toxin type A in pain management.","volume":"43","author":"Aoki","year":"2003","journal-title":"Headache"},{"key":"R2-13-20210112","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","article-title":"Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A.","volume":"26","author":"Aoki","year":"2005","journal-title":"Neurotoxicology"},{"key":"R3-13-20210112","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"R4-13-20210112","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/00002508-200211001-00003","article-title":"Possible mechanisms for the effects of botulinum toxin on pain.","volume":"18","author":"Arezzo","year":"2002","journal-title":"Clin J Pain"},{"key":"R5-13-20210112","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1097\/00002508-200211001-00010","article-title":"A focused review on the use of botulinum toxins for neuropathic pain.","volume":"18","author":"Argoff","year":"2002","journal-title":"Clin J Pain"},{"key":"R6-13-20210112","first-page":"5","article-title":"Botulinum toxin for the treatment of headaches: a review of current practices and evidence based-data.","volume":"18","author":"Ates","year":"2006","journal-title":"Agri"},{"key":"R7-13-20210112","first-page":"201","article-title":"Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.","volume":"46","author":"Bach-Rojecky","year":"2005","journal-title":"Croat Med J"},{"key":"R8-13-20210112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","article-title":"Botulinum toxine type A in experimental neuropathic pain.","volume":"112","author":"Bach-Rojecky","year":"2005","journal-title":"J Neural Transm"},{"key":"R9-13-20210112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2307\/3001536","article-title":"The use of transformations.","volume":"3","author":"Bartlett","year":"1947","journal-title":"Biometrics"},{"key":"R10-13-20210112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-510X(02)00313-1","article-title":"Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study.","volume":"205","author":"Blersch","year":"2002","journal-title":"J Neurol Sci"},{"key":"R11-13-20210112","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2133.2001.03961.x","article-title":"Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry.","volume":"144","author":"Braune","year":"2001","journal-title":"Br J Dermatol"},{"key":"R12-13-20210112","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.870020402","article-title":"Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.","volume":"2","author":"Brin","year":"1987","journal-title":"Mov Disord"},{"key":"R13-13-20210112","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1126\/science.288.5464.306","article-title":"Impaired nociception and pain sensation in mice lacking the capsaicin receptor.","volume":"288","author":"Caterina","year":"2000","journal-title":"Science"},{"key":"R14-13-20210112","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1152\/ajpregu.00446.2006","article-title":"Transient receptor potential ion channels as participants in thermosensation and thermoregulation.","volume":"292","author":"Caterina","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R15-13-20210112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment.","volume":"11","author":"Cruccu","year":"2004","journal-title":"Eur J Neurol"},{"key":"R16-13-20210112","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","article-title":"Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.","volume":"107","author":"Cui","year":"2004","journal-title":"Pain"},{"key":"R17-13-20210112","first-page":"R17","article-title":"Mechanisms of the antinociceptive effect of subcutaneous Botox inhibition of peripheral and central nociceptive processing (abstract).","volume":"365","author":"Cui","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R18-13-20210112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins.","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur J Neurol"},{"key":"R19-13-20210112","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1468-2982.2004.00754.x","article-title":"Botulinum toxin A in the prophylactic treatment of migraine-a randomized, double-blind, placebo-controlled study.","volume":"24","author":"Evers","year":"2004","journal-title":"Cephalalgia"},{"key":"R20-13-20210112","first-page":"97","article-title":"Pressure pain threshold with and without iontophoretic anesthesia of the masseter muscle in asymptomatic males.","volume":"13","author":"Fujisawa","year":"1999","journal-title":"J Orofac Pain"},{"key":"R21-13-20210112","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pain.2006.04.014","article-title":"The effects of Botulinum toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.","volume":"122","author":"Gazerani","year":"2006","journal-title":"Pain"},{"key":"R22-13-20210112","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/08990229109144738","article-title":"Stimulus features relevant to the perception of sharpness and mechanically evoked cutaneous pain.","volume":"8","author":"Greenspan","year":"1991","journal-title":"Somatosens Mot Res"},{"key":"R23-13-20210112","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release.","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"R24-13-20210112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0021-5155(99)00197-5","article-title":"Presynaptic effects of botulinum toxin type A on the neuronally evoked response of albino and pigmented rabbit iris sphincter and dilator muscles.","volume":"44","author":"Ishikawa","year":"2000","journal-title":"Jpn J Ophthalmol"},{"key":"R25-13-20210112","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0363-5023(93)90060-G","article-title":"Use of botulinum toxin in the treatment of hand dystonia.","volume":"18","author":"Jankovic","year":"1993","journal-title":"J Hand Surg Am"},{"key":"R26-13-20210112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(86)90235-6","article-title":"Pressure pain threshold in human temporal region. Evaluation of a new pressure algometer.","volume":"25","author":"Jensen","year":"1986","journal-title":"Pain"},{"key":"R27-13-20210112","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1524-4725.1998.tb04096.x","article-title":"Electromyographic guidance in injecting botulinum toxin.","volume":"24","author":"Klein","year":"1998","journal-title":"Dermatol Surg"},{"key":"R28-13-20210112","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3959(92)90262-A","article-title":"Dynamic and static components of mechanical hyperalgesia in human hairy skin.","volume":"51","author":"Koltzenburg","year":"1992","journal-title":"Pain"},{"key":"R29-13-20210112","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/003655099444597","article-title":"Pressure pain thresholds in different tissues in one body region. The influence of skin sensitivity in pressure algometry.","volume":"31","author":"Kosek","year":"1999","journal-title":"Scand J Rehabil Med"},{"key":"R30-13-20210112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00415-003-0971-x","article-title":"Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.","volume":"250","author":"Kramer","year":"2003","journal-title":"J Neurol"},{"key":"R31-13-20210112","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1113\/jphysiol.1992.sp019068","article-title":"Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin.","volume":"448","author":"LaMotte","year":"1992","journal-title":"J Physiol"},{"key":"R32-13-20210112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1152\/jn.1991.66.1.190","article-title":"Neurogenic hyperalgesia psychophysical studies of underlying mechanisms.","volume":"66","author":"LaMotte","year":"1991","journal-title":"J Neurophysiol"},{"key":"R33-13-20210112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2006.12.004","article-title":"Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain.","volume":"145","author":"Luvisetto","year":"2007","journal-title":"Neuroscience"},{"key":"R34-13-20210112","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov Disord"},{"key":"R35-13-20210112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","article-title":"Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.","volume":"45","author":"Mathew","year":"2005","journal-title":"Headache"},{"key":"R36-13-20210112","doi-asserted-by":"crossref","first-page":"21338","DOI":"10.1016\/S0021-9258(19)36614-1","article-title":"Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid aspartate and met-enkephalin release from synaptosomes Clues to the locus of action.","volume":"267","author":"McMahon","year":"1992","journal-title":"J Biol Chem"},{"key":"R37-13-20210112","doi-asserted-by":"crossref","first-page":"25665","DOI":"10.1074\/jbc.M311515200","article-title":"Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity.","volume":"279","author":"Morenilla-Palao","year":"2004","journal-title":"J Biol Chem"},{"key":"R38-13-20210112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1348-0421.1995.tb02184.x","article-title":"Structure and function of Clostridium botulinum toxins.","volume":"39","author":"Oguma","year":"1995","journal-title":"Microbiol Immunol"},{"key":"R39-13-20210112","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.","volume":"18","author":"Pacchetti","year":"2003","journal-title":"Mov Disord"},{"key":"R40-13-20210112","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/BF03022619","article-title":"The effects of botulinum toxin A on mechanical and cold allodynia in a rat model of neuropathic pain.","volume":"53","author":"Park","year":"2006","journal-title":"Can J Anaesth"},{"key":"R41-13-20210112","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0041-0101(96)00180-8","article-title":"Pharmacologic characterization of botulinum toxin for basic science and medicine.","volume":"35","author":"Pearce","year":"1997","journal-title":"Toxicon"},{"key":"R42-13-20210112","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0006-2952(00)00260-4","article-title":"Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.","volume":"59","author":"Purkiss","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R43-13-20210112","doi-asserted-by":"crossref","first-page":"542S","DOI":"10.1042\/bst025542s","article-title":"Capsaicin stimulates release of substance P from dorsal root ganglion neurons via two distinct mechanisms.","volume":"25","author":"Purkiss","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"R44-13-20210112","first-page":"324","article-title":"The influence of cutaneous tissue afferents on masticatory pain-pressure thresholds.","volume":"10","author":"Reid","year":"1996","journal-title":"J Orofac Pain"},{"key":"R45-13-20210112","first-page":"II","article-title":"A double-blind randomised placebo-controlled exploratory study comparing injection sites with low doses of botulinum toxin type A in the prevention of episodic migraine.","volume":"252","author":"Saper","year":"2005","journal-title":"J Neurol"},{"key":"R46-13-20210112","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2133.1997.d01-1233.x","article-title":"Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.","volume":"136","author":"Schnider","year":"1997","journal-title":"Br J Dermatol"},{"key":"R47-13-20210112","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00702-007-0832-3","article-title":"Evidence based medicine on the use of botulinum toxin for headache disorders.","volume":"115","author":"Schulte-Mattler","year":"2008","journal-title":"J Neural Transm"},{"key":"R48-13-20210112","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2007.03.023","article-title":"Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.","volume":"260","author":"Schulte-Mattler","year":"2007","journal-title":"J Neurol Sci"},{"key":"R49-13-20210112","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1152\/jn.1998.80.6.2801","article-title":"Flare and hyperalgesia after intradermal capsaicin injection in human skin.","volume":"80","author":"Serra","year":"1998","journal-title":"J Neurophysiol"},{"key":"R50-13-20210112","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1468-2982.2006.01114.x","article-title":"Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.","volume":"26","author":"Silberstein","year":"2006","journal-title":"Cephalalgia"},{"key":"R51-13-20210112","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.4065\/80.9.1126","article-title":"Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.","volume":"80","author":"Silberstein","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"R52-13-20210112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1468-1331.2001.00261.x","article-title":"Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study.","volume":"8","author":"Swartling","year":"2001","journal-title":"Eur J Neurol"},{"key":"R53-13-20210112","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1213\/01.ane.0000194447.46763.73","article-title":"A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model.","volume":"102","author":"Sycha","year":"2006","journal-title":"Anesth Analg"},{"key":"R54-13-20210112","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/08990220500420475","article-title":"Influence of surface anesthesia on the pressure pain threshold measured with different-sized probes.","volume":"22","author":"Takahashi","year":"2005","journal-title":"Somatosens Mot Res"},{"key":"R55-13-20210112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(86)92070-2","article-title":"Double-blind study of botulinum toxin in spasmodic torticollis.","volume":"2","author":"Tsui","year":"1986","journal-title":"Lancet"},{"key":"R56-13-20210112","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pain.2006.10.030","article-title":"Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.","volume":"130","author":"Tugnoli","year":"2007","journal-title":"Pain"},{"key":"R57-13-20210112","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1212\/01.WNL.0000086374.92906.6A","article-title":"A randomized, double-blind, placebo-controlled study on analgesic effects of botulinum toxin A.","volume":"61","author":"Voller","year":"2003","journal-title":"Neurology"},{"key":"R58-13-20210112","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","article-title":"Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.","volume":"38","author":"Welch","year":"2000","journal-title":"Toxicon"},{"key":"R59-13-20210112","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0304-3959(94)00132-X","article-title":"Heat pain thresholds: normative data and repeatability.","volume":"60","author":"Yarnitsky","year":"1995","journal-title":"Pain"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1016\/j.pain.2008.10.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:13:30Z","timestamp":1786036410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200901000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2008.10.005","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1140848.618934","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1140848.597935","asserted-by":"object"}]},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}